körülvesz Remeg tanterv kwok nash fibroscan cap Általában véve ajándék klub
Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study | PLOS ONE
Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study
The diagnostic conundrum in non-alcoholic fatty liver disease
FibroScan - Because liver health matters
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
Article|International Journal of Current Research and Review
How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis? | SpringerLink
Frontiers | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement
Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
Application of transient elastography in nonalcoholic fatty liver disease
Frontiers | Liver Steatosis: Better Predictor of CKD in MAFLD Than Liver Fibrosis as Determined by Transient Elastography With Controlled Attenuation Parameter
körülvesz Remeg tanterv kwok nash fibroscan cap Általában véve ajándék klub
Non-invasive tests of non-alcoholic fatty liver disease | Chinese Medical Journal
Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes - Kuchay - 2021 - JGH Open - Wiley Online Library
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery | Scientific Reports
Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease
FibroScan - Because liver health matters
The diagnostic conundrum in non-alcoholic fatty liver disease
körülvesz Remeg tanterv kwok nash fibroscan cap Általában véve ajándék klub
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
